Optimal Blood Pressure Thresholds for Minimal Coronary Artery Disease Risk in Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We aimed to determine optimal blood pressure (BP) thresholds for minimizing coronary artery disease (CAD) risk in people with childhood-onset type 1 diabetes. RESEARCH DESIGN AND METHODS: The Pittsburgh Epidemiology of Diabetes Complications (EDC) Study participants without known CAD at baseline (n = 605) were included and followed for 25 years. The associations of time-weighted BP measures (systolic BP [SBP], diastolic BP [DBP], and mean arterial pressure) with incident CAD were examined by using Cox models. Areas under the receiver operating characteristic curve (AUC) were summarized by different cut points of time-weighted BPs. Risk stratification analyses were then performed on the basis of BP (<120/80 vs. ≥120/80 mmHg) and HbA1c (<8% vs. ≥8%). RESULTS: Baseline mean age was 27 years. Half of the cohort were women and 98% were white. A dose-gradient association was observed for categorized time-weighted BPs and CAD. According to AUC, the optimal cut point for SBP was 120 mmHg and for DBP was 80 mmHg. BP ≥120/80 mmHg was associated with a 1.9 times (95% CI 1.4, 2.6) greater risk of developing CAD than that for BP <120/80 mmHg. Participants with good control of both BP and HbA1c had BP <120/80 mmHg and HbA1c <8%. Those with only high BP (hazard ratio [HR] 2.0 [95% CI 1.1, 3.9]) carried a similar risk of developing CAD as those with only high HbA1c (HR 1.6 [95% CI 0.97, 2.8]). CONCLUSIONS: The optimal BP threshold associated with minimal CAD risk is 120/80 mmHg in young adults with childhood-onset type 1 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antiplatelet agents may be beneficial in individuals with T1DM without symptomatic ASCVD who have at least one additional major CV risk factor.800”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [800]
Citations
Cites
pROC: an open-source package for R and S+ to analyze and compare ROC curves
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697
Enzymatic Determination of Total Serum Cholesterol
Allain, C. C., Poon, L. S., Chan, C. S. G., Richmond, W., & Fu, P. C. (1974) · Clinical Chemistry · doi:10.1093/clinchem/20.4.470 · Cited by 9,125
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
The J-Curve Phenomenon in Hypertension
Kang, Y.-Y., & Wang, J.-G. (2016) · Pulse · doi:10.1159/000446922 · Cited by 1,530
The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group (2016) · Diabetes Care · doi:10.2337/dc15-1990 · Cited by 712
Diabetes and hypertension: the bad companions
Ferrannini, E., & Cushman, W. C. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60987-8 · Cited by 695
OptimalCutpoints: An R Package for Selecting Optimal Cutpoints in Diagnostic Tests
López-Ratón, M., Rodríguez-Álvarez, M. X., Suárez, C. C., & Sampedro, F. G. (2014) · Journal of Statistical Software · doi:10.18637/jss.v061.i08 · Cited by 548
Orchard, T. J., Dorman, J. S., Maser, R. E., Becker, D. J., Drash, A. L., Ellis, D., LaPorte, R. E., & Kuller, L. H. (1990) · Diabetes · doi:10.2337/diab.39.9.1116 · Cited by 540
Self-citationThe 30-Year Natural History of Type 1 Diabetes Complications
Pambianco, G., Costacou, T., Ellis, D., Becker, D. J., Klein, R., & Orchard, T. J. (2006) · Diabetes · doi:10.2337/db05-1423 · Cited by 493
Self-citation10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s010 · Cited by 471
Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events
McEvoy, J. W., Chen, Y., Rawlings, A., Hoogeveen, R. C., Ballantyne, C. M., Blumenthal, R. S., Coresh, J., & Selvin, E. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.07.754 · Cited by 350
The hypertension detection and follow-up program
(1976) · Preventive Medicine · doi:10.1016/0091-7435(76)90039-6 · Cited by 347
and the WHO Multinational Study Group, Fuller, J., Stevens, L., & Wang, S.-L. (2001) · Diabetologia · doi:10.1007/pl00002940 · Cited by 301
Wagener, D. K., Sacks, J. M., LaPorte, R. E., & MaCgregor, J. M. (1982) · Diabetes · doi:10.2337/diab.31.2.136 · Cited by 218
Lipid and Blood Pressure Treatment Goals for Type 1 Diabetes
Orchard, T. J., Forrest, K. Y.-Z., Kuller, L. H., & Becker, D. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1053 · Cited by 192
Self-citationWarnick, G. R., & Albers, J. J. (1978) · Clinical Chemistry · doi:10.1093/clinchem/24.6.900 · Cited by 179
Maahs, D. M., Kinney, G. L., Wadwa, P., Snell-Bergeon, J. K., Dabelea, D., Hokanson, J., Ehrlich, J., Garg, S., Eckel, R. H., & Rewers, M. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.301 · Cited by 139
Prince, C. T., Becker, D. J., Costacou, T., Miller, R. G., & Orchard, T. J. (2007) · Diabetologia · doi:10.1007/s00125-007-0797-7 · Cited by 125
Self-citationMiller, R. G., Mahajan, H. D., Costacou, T., Sekikawa, A., Anderson, S. J., & Orchard, T. J. (2016) · Diabetes Care · doi:10.2337/dc16-1162 · Cited by 121
Self-citationCostacou, T., & Orchard, T. J. (2018) · Diabetes Care · doi:10.2337/dc17-1118 · Cited by 121
Self-citationFranklin, S. S., Gokhale, S. S., Chow, V. H., Larson, M. G., Levy, D. A., Vasan, R. S., Mitchell, G. F., & Wong, N. D. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.04581 · Cited by 103
Use of Long-term Cumulative Blood Pressure in Cardiovascular Risk Prediction Models
Pool, L. R., Ning, H., Wilkins, J., Lloyd-Jones, D. M., & Allen, N. B. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.2763 · Cited by 92
Ellis, D., Coonrod, B. A., Dorman, J. S., Kelsey, S. F., Becker, D. J., Avner, E. D., & Orchard, T. J. (1989) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(89)80039-3 · Cited by 89
Self-citationZgibor, J. C., Ruppert, K. M., Orchard, T. J., Soedamah‐Muthu, S. S., Fuller, J., Chaturvedi, N., & Roberts, M. S. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.02.009 · Cited by 50
Self-citationEvaluating the Accuracy of an Aneroid Sphygmomanometer in a Clinical Trial Setting
Ma, Y., Temprosa, M., Fowler, S., Prineas, R. J., Montez, M. G., Brown-Friday, J., Carrion-Petersen, M. L., & Whittington, T. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2008.338 · Cited by 46
Changing Impact of Modifiable Risk Factors on the Incidence of Major Outcomes of Type 1 Diabetes
Miller, R. G., Secrest, A. M., Ellis, D., Becker, D. J., & Orchard, T. J. (2013) · Diabetes Care · doi:10.2337/dc13-1142 · Cited by 44
Self-citationPredictive Value of Cumulative Blood Pressure for All-Cause Mortality and Cardiovascular Events
Wang, Y. X., Song, L., Xing, A. J., Gao, M., Zhao, H. Y., Li, C. H., Zhao, H., Chen, S., Lu, C. Z., & Wu, S. L. (2017) · Scientific Reports · doi:10.1038/srep41969 · Cited by 43
Association Between Blood Pressure and Adverse Renal Events in Type 1 Diabetes
Ku, E., McCulloch, C. E., Mauer, M. S., Gitelman, S. E., Grimes, B. A., & Hsu, C. (2016) · Diabetes Care · doi:10.2337/dc16-0857 · Cited by 37
Sibal, L., LAW, H. N., Gebbie, J., Dashora, U. K., Agarwal, S. C., & Home, P. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1372.037 · Cited by 15
Cited by
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Tobias, D. K., Merino, J., Ahmad, A., Aiken, C., Benham, J. L., Bodhini, D., Clark, A. L., Colclough, K., Corcoy, R., Cromer, S. J., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02502-5 · Cited by 217
Banerjee, D., Winocour, P. H., Chowdhury, T. A., De, P., Wahba, M. M., Montero, R., Fogarty, D. G., Frankel, A., Karalliedde, J. J., Mark, P. B., et al. (2022) · BMC Nephrology · doi:10.1186/s12882-021-02587-5 · Cited by 107
Prevention of Cardiovascular Disease in Type 1 Diabetes
Manrique‐Acevedo, C., Hirsch, I. B., & Eckel, R. H. (2024) · New England Journal of Medicine · doi:10.1056/nejmra2311526 · Cited by 79
Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors
Wu, M., Chandramouli, C., Wong, P., Chan, Y., Li, H., Yu, S.-Y., Tse, Y.-K., Ren, Q. W., Yu, S.-Y., Tse, H., et al. (2022) · Diabetes & Metabolism · doi:10.1016/j.diabet.2022.101367 · Cited by 56
Metadata
- Authors
- Guo, J., Brooks, M. M., Muldoon, M. F., Naimi, A. I., Orchard, T. J., & Costacou, T.
- Affiliations
- University of Pittsburgh (US)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2019-06-27
- Volume
- 42
- Issue
- 9
- Pages
- 1692-1699
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC6702601
- OpenAlex
- W2955848929
- Cited by
- 22
- References
- 29
- Citations by year
- 2025: 4 · 2024: 2 · 2023: 3 · 2022: 6 · 2021: 4 · 2020: 2 · 2019: 1
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-034818)
- Rossi Memorial Fund
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 1 diabetes, coronary artery disease, blood pressure thresholds, systolic blood pressure, diastolic blood pressure, mean arterial pressure, HbA1c, cardiovascular risk stratification, childhood-onset diabetes, Pittsburgh Epidemiology of Diabetes Complications Study, dose-response relationship
- MeSH terms
- Adolescent, Adult, Blood Pressure, Blood Pressure Determination, Child, Coronary Artery Disease, Diabetes Mellitus, Type 1, Diabetic Angiopathies, Female, Humans, Hypertension, Male, Reference Values, Risk Factors, Cohort Studies, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.